Bayer shares slide after Monsanto’s Roundup cancer trial

Shares in Bayer plunged more than 10 percent to their lowest in almost two years after a California jury ordered the German company’s subsidiary Monsanto to pay $289 million in damages last week.

Leave a Reply

Read the original at Reuters: Business News.